Please login to the form below

Not currently logged in

CROS NT names Mark Paul as senior VP of US operations

He joins from Veracity Logic

CROS NTInternational contract research organisation CROS NT has appointed Mark Paul as senior vice president of its US operations.

Paul will be responsible for the company's workings in the US and will represent US interests on the global leadership team.

Commenting on his appointment, Paul said: “I am looking forward to joining CROS NT; the company has a great reputation and a strong team in the US and I am looking forward to working with them and helping the business to grow here. 

“CROS NT has built up a portfolio of business through a combination of strong expertise and excellent customer service; I will continue to grow the US operation with those values in mind”.

Paul brings a wealth of experience to the role and has served in senior management roles at Quintiles, Health Decisions, StatWorks and most recently at Veracity Logic.

Andrew MacGarvey, CEO of CROS NT, added: “I am delighted to welcome Mark to our company. We are growing our customer base in the United States and increasing the size of our group here. 

“Mark has great experience in delivering global projects and in growing and developing operational teams. He will oversee our continued growth in the region and will work closely with our customers to ensure they receive the highest levels of service."

18th June 2015

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...